Corona Remedies Limited
ListedMainboardHealthcare & Pharmaceuticals · NSE / BSE
Corona Remedies Limited, incorporated in August 2004, is a pharmaceutical company engaged in the development, manufacturing, and marketing of products across key therapeutic areas including women’s healthcare, cardiology, pain management, urology, and multispecialty segments. As of December 2024, its portfolio includes 67 brands covering women’s health, cardio-diabetic care, pain relief, urology, and multispecialty products such as vitamins, minerals, nutrition, gastrointestinal, and respiratory medications. The company has established a strong pan-India presence with 2,598 medical representatives across 22 states, ensuring deep engagement with healthcare professionals and hospitals. It operates two manufacturing facilities in Gujarat, supporting its production and quality-focused growth strategy in the Indian Pharmaceutical Market.
Price Band
₹1008 – ₹1062
Issue Size
₹655 Cr
Lot Size
14 shares
GMP
₹344
+32.4%
Est. Listing
₹1406
at current GMP
Subscribed
144.49x
overall
Open
8 Dec 2025
Close
10 Dec 2025
Allotment
11 Dec 2025
Refund
12 Dec 2025
Demat Credit
13 Dec 2025
Listing
15 Dec 2025
Last updated 12 days ago
Official Registrar Verification
Corona Remedies Limited Allotment Status
Designated Registrar: Bigshare Services Private Limited
Allotment Date
11 Dec 2025
Basis finalization
Refunds Initiate
12 Dec 2025
Mandate release
Demat Credit
13 Dec 2025
Shares in demat
Listing Debut
15 Dec 2025
Trading begins
How to Check Corona Remedies Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Bigshare Services Private Limited's allotment portal.
- Select Corona Remedies Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Corona Remedies Limited Public Issue & Market Profile
Corona Remedies Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹655.37 Crores. The shares are offered at a price band of ₹1008 to ₹1062 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Public Issue & Allotment Procedure:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 14 shares (approx. ₹14,868 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Official Allotment Timelines & Registrar Guidance:
Allotment reconciliation will be managed by Bigshare Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-12-13, while un-allotted funds or UPI block mandates will be released on 2025-12-12.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.